...
Richard Norman (Unlicensed) (Pistoia Alliance)
Craig Dickinson (Unlicensed) (Eli Lilly)
- Chris Lloyd (Deactivated) (MedImmune)
- Carmen Nitsche (Deactivated) (Pistoia Alliance)
- Kieran Todd (Deactivated) (GSK)
Discussion items
| Time | Item | Who | Notes |
|---|---|---|---|
| 17:00 - 18:00 (60 mins) | >Discussion on identifying ‘value’ assays >Use of sequence/structure in developability risk prediction | Richard, All | >Collated criteria for building set of ‘value’ assays >Highlight ‘gaps’ in current practices
|
| If time permits | >Wiki page and WoW >EMBL-EBI presentation outline. |
Minutes
Wiki page and Ways of Working
...